Hypercalcemia Associated with Parathyroid Carcinoma

• FDA approval · 2018-04-30
  FDA Approved: CINACALCET — Original Application (Strides Pharma Science Limited)

  FDA approved CINACALCET from Strides Pharma Science Limited under an Original Application (ANDA) as a generic. The indications include secon…

• FDA approval · 2011-02-25
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  FDA approved Amgen's supplemental application for Sensipar (cinacalcet hydrochloride).

• FDA approval · 2008-12-19
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  FDA approves a supplemental NDA for SENSIPAR (cinacalcet hydrochloride) submitted by Amgen, resulting in updated labeling and potential new/…